STARPAX
LIVE

Serial Number

88423029

Owner

Starpax Medical Inc.

Attorney

Alison M. Caless

Filing Date

May 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

STARPAX Trademark

Serial Number: 88423029 • Registration: 7797794

STARPAX is a trademark filed by Starpax Medical Inc. on May 9, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Starpax Medical Inc. (2 trademarks)

Suite 2500
Montréal, Québec H3B4N4 , CA

Entity Type: 03

STARPAX BIOPHARMA INC.

1100 BOUL. RENÉ-LÉVESQUE WEST
MONTRÉAL H3B4N4 , CA

Entity Type: 03

Trademark Details

Filing Date

May 9, 2019

Registration Date

May 20, 2025

Published for Opposition

April 1, 2025

Goods & Services

active biochemical formulations in the nature of active biochemical ingredients for use in the manufacture of anti-cancer drugs

Health care services for treating cancer and diseases or disorders located in low oxygen areas of the human body and the animal body; medical analysis services for cancer diagnosis and prognosis; medical diagnostic services

anti-cancer preparations; bacteria capable to transport therapeutic agents and imagery markers into cancer tumors and organs for the treatment of cancer and other diseases requiring targeted delivery; bacteria capable to transport therapeutic agents and imagery markers into organs for the treatment of diseases or disorders located in low oxygen areas of the human body and the animal body; pharmaceutical preparations and compositions for the treatment and prevention of cancer and diseases or disorders located in low oxygen areas of the human body and the animal body; pharmaceutical preparations and substances for the treatment of cancer and diseases or disorders located in low oxygen areas of the human body and the animal body; therapeutic agents and imagery markers for delivery of cancer treatment

Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 20, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 20, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 12, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 10, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 10, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 10, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 10, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 6, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 12, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 12, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 12, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 6, 2025 RCCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 25, 2024 ASGN
ASSIGNED TO EXAMINER
Aug 15, 2024 DOCK
ASSIGNED TO EXAMINER
Aug 15, 2024 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 15, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 27, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 27, 2023 GNSL
SUSPENSION LETTER WRITTEN
Nov 27, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 27, 2023 CRFA
ASSIGNED TO LIE
Nov 26, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 21, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 17, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 17, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 17, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 13, 2023 RCCK
ASSIGNED TO EXAMINER
Apr 11, 2023 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 18, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 26, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 26, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 26, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 25, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 24, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 24, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jan 24, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 6, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 6, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 6, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 24, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 29, 2019 NWOS
NEW APPLICATION ENTERED
May 13, 2019 NWAP